Global Perspective on Healthcare Data as the New Driver of Innovation in Diagnostics and Patient Care
Presented by: Michael Simpson
Surviving & Thriving Past the “Regulatory Perfect Storm” Thinking Strategically about What Happens Next after Labs Weather the “Perfect Storm”
Presented by: Robert Michel
Surviving & Thriving Past the "Regulatory Perfect Storm" Thinking Strategically about What Happens Next after Labs Weather the "Perfect Storm"
PDF copy of Session PowerPoint Slides
Panel: Timing and Implications of FDA LDT Rule; Reforms to CLIA Regulations; Wider Use of Z-Code by Payers
Presented by: William Morice, Tim Stenzel, Lale White, Gabriel Bien-Willner
Panel: Timing and Implications of FDA LDT Rule; Reforms to CLIA Regulations; Wider Use of Z-Code by Payers
PDF copy of the Presentation Slides
New Developments at the FDA: Draft LDT Rule, Harmonization of ISO 13485, Memo on Reclassification of Certain Assays, and More
Presented by: Timothy Stenzel
New Developments at the FDA: Draft LDT Rule, Harmonization of ISO 13485, Memo on Reclassification of Certain Assays, and More
PDF copy of the Presentation Slides
MolDx and Z-identifier Codes: Why and How and the Future
Presented by: Gabriel Bien-willner
MolDx and Z-identifier Codes: Why and How and the Future
PDF copy of the Presentation Slides
